Medline Inc. Class A Common Stock vs Onto Innovation — how do they compare? Medline Inc. Class A Common Stock trades at $35.74 (market cap $31.36B), while Onto Innovation trades at $298.55 (market cap $14.36B). The key difference: Medline Inc. Class A Common Stock is far larger — about 2.2× Onto Innovation's market cap, and Onto Innovation is trading nearer its 52-week high, Medline Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medline Inc. Class A Common Stock for 0 Days and Onto Innovation for 5 Days on average.
| MDLN | ONTO | |
|---|---|---|
Market Cap | $31.36B | $14.36B |
Volume | 10,191,251 | 761,617 |
Sector | Health | Technology |
52-Week High | $49.99 | $378.45 |
52-Week Low | $31.64 | $121.34 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $41.32B | $13.95B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.
Read more on MDLN →Onto Innovation provides process control solutions for semiconductor manufacturing. Its inspection and metrology systems help chipmakers measure, analyze, and detect defects on wafers and advanced packages.
Read more on ONTO →